BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27021232)

  • 1. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
    Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
    J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.
    Guo QY; Miao LN; Li B; Ma FZ; Liu N; Cai L; Xu ZG
    Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E708-16. PubMed ID: 21285403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
    Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.
    Xu HZ; Cheng YL; Wang WN; Wu H; Zhang YY; Zang CS; Xu ZG
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16ink4a Expression Is Increased through 12-Lipoxygenase in High Glucose-Stimulated Glomerular Mesangial Cells and Type 2 Diabetic Glomeruli.
    Zhang YY; Guo QY; Wu MY; Zang CS; Ma FZ; Sun T; Wang WN; Miao LN; Xu ZG
    Nephron; 2015; 130(2):141-50. PubMed ID: 26022507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of 12-Lipoxygenase and Its Interaction with Angiotensin II on p21 and p27 Expression in Diabetic Nephropathy.
    Zhang YY; Wang WN; Su SS; Chen B; Sun WX; Wu H; Cheng YL; Xu ZG
    Nephron; 2019; 142(1):61-70. PubMed ID: 30677774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of nephrin according to glomerular size in early diabetic kidney disease.
    Kim JJ; Li JJ; Jung DS; Kwak SJ; Ryu DR; Yoo TH; Han SH; Choi HY; Kim HJ; Han DS; Kang SW
    J Am Soc Nephrol; 2007 Aug; 18(8):2303-10. PubMed ID: 17599973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
    Zhang Z; Zhang Y; Ning G; Deb DK; Kong J; Li YC
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15896-901. PubMed ID: 18838678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone.
    Miceli I; Burt D; Tarabra E; Camussi G; Perin PC; Gruden G
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F381-90. PubMed ID: 19906946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.
    Takahashi A; Fukusumi Y; Yamazaki M; Kayaba M; Kitazawa Y; Tomita M; Kawachi H
    J Nephrol; 2014 Dec; 27(6):627-34. PubMed ID: 25298195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1.
    Ren Z; Liang W; Chen C; Yang H; Singhal PC; Ding G
    Cell Signal; 2012 Feb; 24(2):443-450. PubMed ID: 21982880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy.
    Xu ZG; Li SL; Lanting L; Kim YS; Shanmugam N; Reddy MA; Natarajan R
    Kidney Int; 2006 Feb; 69(3):512-9. PubMed ID: 16514433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.
    Hayashi K; Sasamura H; Nakamura M; Sakamaki Y; Azegami T; Oguchi H; Tokuyama H; Wakino S; Hayashi K; Itoh H
    Kidney Int; 2015 Oct; 88(4):745-53. PubMed ID: 26108068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Products of 12/15-lipoxygenase upregulate the angiotensin II receptor.
    Xu ZG; Yuan H; Lanting L; Li SL; Wang M; Shanmugam N; Kato M; Adler SG; Reddy MA; Natarajan R
    J Am Soc Nephrol; 2008 Mar; 19(3):559-69. PubMed ID: 18235084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
    Kamal F; Yanakieva-Georgieva N; Piao H; Morioka T; Oite T
    Nephron Exp Nephrol; 2010; 115(3):e69-79. PubMed ID: 20424485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
    Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
    J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
    Zhang Y; Deb DK; Kong J; Ning G; Wang Y; Li G; Chen Y; Zhang Z; Strugnell S; Sabbagh Y; Arbeeny C; Li YC
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F791-801. PubMed ID: 19535571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.
    Deb DK; Sun T; Wong KE; Zhang Z; Ning G; Zhang Y; Kong J; Shi H; Chang A; Li YC
    Kidney Int; 2010 Jun; 77(11):1000-9. PubMed ID: 20182412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.